<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04722432</url>
  </required_header>
  <id_info>
    <org_study_id>CE 20.220</org_study_id>
    <nct_id>NCT04722432</nct_id>
  </id_info>
  <brief_title>Evaluation of Deployment Capability and Accuracy of an Outside the Scope (OTS), Detachable Catheter System for Ablation of Peripheral Lung Lesions: An Ex-Vivo Human Lung Model Study</brief_title>
  <official_title>Evaluation of Deployment Capability and Accuracy of an Outside the Scope (OTS), Detachable Catheter System for Ablation of Peripheral Lung Lesions: An Ex-Vivo Human Lung Model Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A novel OTS detachable probe system carried outside and along the flexible bronchoscope has&#xD;
      been developed. Using this novel system, the operator can deploy the probe in the target&#xD;
      bronchus and lesion and completely detach the scope from the probe.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lung ablative therapies have growing interest in the treatment of early-stage primary lung&#xD;
      cancer in surgical high-risk patients and as part of multimodal treatment in patients with&#xD;
      large lesions or metastatic malignant disease in the lungs. Endobronchial ablative strategies&#xD;
      allow deliver y of these therapies through a natural orifice and minimally invasive approach,&#xD;
      potentially improving safety and reducing related morbidity. Application and deployment of&#xD;
      this system allows the operator to have constant control of the airway, preventing&#xD;
      life-threatening hemoptysis and other complications. We hypothesize that this novel&#xD;
      detachable OTS system can be successfully deployed in the peripheral parenchymal target with&#xD;
      potential clinical applications in the near future.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 16, 2020</start_date>
  <completion_date type="Anticipated">October 16, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 16, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>accuracy of the deployment method</measure>
    <time_frame>Time of procedure</time_frame>
    <description>will be measured by bidimensional fluoroscopy images (antero-posterior and latero-lateral). The deployment will be considered successful if the tip of the probe is positioned at a distance less than 5 mm in both axes from the target model and stay stable in place over 5 minutes of ventilation.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Système de cathéter détachable dehors du scope (DDS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Outside the Scope (OTS), Detachable Catheter System</intervention_name>
    <description>Evaluation of Deployment Capability and Accuracy of an Outside the Scope (OTS), Detachable Catheter System for Ablation of Peripheral Lung Lesions: An Ex-Vivo Human Lung Model Study</description>
    <arm_group_label>Système de cathéter détachable dehors du scope (DDS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who follow surgery for the removal of diseased lungs before being submitted&#xD;
             to a bilateral lung transplant.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Adeline Jouquan, MsC</last_name>
    <phone>514-890-8000</phone>
    <phone_ext>26214</phone_ext>
    <email>adeline.jouquan.chum@ssss.gouv.qc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHUM</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adeline Jouquan, MSc</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>26214</phone_ext>
      <email>adeline.jouquan.chum@ssss.gouv.qc.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 16, 2020</study_first_submitted>
  <study_first_submitted_qc>January 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

